Allergan Inc. v. Merz Pharmaceuticals LLC, et al.
Published: Feb. 23, 2013 | Result Date: Mar. 7, 2012 | Filing Date: Jan. 1, 1900 |Case number: 8:2011-cv-00446 Bench Decision – Preliminary Injunction Granted
Court
USDC Central
Attorneys
Plaintiff
Molly J. Magnuson
(Law Offices of Michael S. Magnuson)
Daniel M. Petrocelli
(O'Melveny & Myers LLP)
Brett J. Williamson
(O'Melveny & Myers LLP)
Defendant
Sharyl A. Reisman
(Jones Day)
Frederick L. McKnight
(Jones Day)
Steven M. Zadravecz
(Jones Day)
Facts
Allergan Inc. manufactured Botox, a popular anti-wrinkle treatment and the company's bestseller. In 2010, Allergan's sales representatives resigned their employment and thereafter accepted positions with rival Mertz Pharmaceuticals LLC just as it was rolling out its rival drug. Allergan sued Mertz for allegedly stealing its customer lists and other trade secrets.
Result
Allergan was successful in obtaining a preliminary injunction enjoining the sale of Mertz's Xeomin for a limited period of time.
For reprint rights or to order a copy of your photo:
Email
jeremy@reprintpros.com
for prices.
Direct dial: 949-702-5390